<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03703037</url>
  </required_header>
  <id_info>
    <org_study_id>GI17-00009</org_study_id>
    <nct_id>NCT03703037</nct_id>
  </id_info>
  <brief_title>Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Postterm Pregnancies</brief_title>
  <official_title>Clinical Utility of Uterine, Fetal Cerebral Doppler and Oligohydramnios to Predict Abnormal Heart Rate Tracings in Pregnancies at or Beyond 41 Weeks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Universitario Dr. Jose E. Gonzalez</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To estimate the value of uterine, fetal cerebral Doppler and oligohydramnios to
      predict abnormal fetal heart rate tracings in pregnancies at or beyond 41 weeks
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a nested case-control study that was conducted at University Hospital Dr. Jose
      E. Gonzalez after the approval of Institutional ethical committee. Women with low risk late
      term or postterm pregnancy (at least 41 weeks) with confirm gestational age who will be
      referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour
      according institutional protocol will be recruited and constitute the cohort.

      Cases will be patients with abnormal intrapartum cardiotocogram (category III fetal heart
      rate tracing). For each case, four controls will be matched. The primary outcome will be to
      obtain odds ratios for the Doppler parameters (middle cerebral artery pulsatility index, mean
      uterine artery pulsatility index and Middle cerebral artery pulsatility index to mean uterine
      artery pulsatility index ratio) and amniotic fluid index that would be associated with
      intrapartum category III fetal heart rate tracing.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">October 1, 2019</completion_date>
  <primary_completion_date type="Actual">February 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Category III fetal heart rate tracings</measure>
    <time_frame>24 hours</time_frame>
    <description>Absent baseline fetal heart rate variability and any of the following: recurrent late decelerations, recurrent variable decelerations, bradycardia, sinusoidal pattern</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Middle cerebral artery pulsatility index</measure>
    <time_frame>24 hours before delivery</time_frame>
    <description>The middle cerebral artery pulsatility index will be obtained in a transversal view of the fetal head, at the level of its origin from the circle of Willis. Measurements will be obtained during periods of fetal apnea, and the angle of insonation will be maintained as close to 0° as possible when interrogating the middle cerebral artery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean uterine artery pulsatility index</measure>
    <time_frame>24 hours before delivery</time_frame>
    <description>The probe will be placed on the lower quadrant of the abdomen, angled medially, and again color Doppler imaging will be used to identify the uterine artery at the apparent crossover with the external iliac artery. Measurements will be taken approximately 1 cm distal to the crossover point. In all cases, once it had been ensured that the angle was less than 20◦, the pulsed Doppler gate will be placed over the whole width of the vessel. Angle correction was then applied and the signal updated until three to five similar consecutive waveforms had been obtained. Mean pulsatility index will be calculated as the average pulsatility index of right and left arteries.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio</measure>
    <time_frame>24 hours before delivery</time_frame>
    <description>The ratio between the pulsatility index of the middle cerebral artery and the mean pulsatility index value of both uterine arteries.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oligohydramnios</measure>
    <time_frame>24 hours before delivery</time_frame>
    <description>Amniotic fluid index (Assessed acording to four-quadrant technique)</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">227</enrollment>
  <condition>Abnormality in Fetal Heart Rate or Rhythm</condition>
  <condition>Ultrasound</condition>
  <condition>Late Pregnancy</condition>
  <arm_group>
    <arm_group_label>Cohort</arm_group_label>
    <description>This will be a nested case-control study. Women with low risk pregnancies at or beyond 41 weeks, who will be referred to our Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according institutional protocol will constitute the cohort.
Then women with intrapartum abnormal fetal heart rate tracings (cases) will be identified and match with controls. The primary outcome will be to obtain odds ratios for the Doppler ultrasound parameters (middle cerebral artery pulsatility index, mean uterine artery pulsatility index and Middle cerebral artery pulsatility index to mean uterine artery pulsatility index ratio) and Ultrasound assessment of amniotic fluid index that would be associated with intrapartum category III fetal heart rate tracing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cases</arm_group_label>
    <description>Cases will be patients with abnormal intrapartum cardiotocogram (category III fetal heart rate tracing).
Intervention: Ultrasound and Doppler ultrasound</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Those will be patients with normal intrapartum cardiotocogram (category I fetal heart rate tracing) or category II that converted into category I after intrauterine resuscitation methods.
Intervention: Ultrasound and Doppler ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ultrasound and Doppler ultrasound</intervention_name>
    <description>Assessment of fetal cerebral and maternal uterine pulsatility index using Doppler ultrasound. Measurement of amniotic fluid index according to four-quadrant technique.</description>
    <arm_group_label>Cases</arm_group_label>
    <arm_group_label>Cohort</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
    <other_name>Pulsatility index</other_name>
    <other_name>Amniotic fluid index</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with low risk late term or postterm pregnancy (at least 41 weeks) with confirm
        gestational age by first trimester ultrasound examination, who will be referred to our
        Maternal-fetal unit and admitted 1 to 2 days prior to induction of labour according
        institutional protocol.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancy

          -  Gestational age of at least 287 days (41 weeks)

          -  Low risk pregnancy (defined as the absence of maternal or fetal complications other
             than postterm pregnancy)

        Exclusion Criteria:

          -  Twin or multiple gestation

          -  Uncertain gestational age

          -  Non vertex presentation

          -  Estimated fetal weight below the 10th percentile for gestational age (Hadlock´s
             formula)

          -  Fetal macrosomia (estimated fetal weight ≥ 4 Kilos) diagnosed by clinical measurement
             (Johnson´s technique) or ultrasound measurement (Hadlock´s formula).

          -  Fetal abnormalities found on routine anomaly scan.

          -  Maternal medical disorder (preeclampsia, chronic hypertension, diabetes, lupus,
             hyperthyroidism)

          -  Prelabour rupture of membranes

          -  Antepartum hemorrhage

          -  Any fetopelvic disproportion that could create dystocia during labor.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Flavio Hernández-Castro, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Dr. José Eleuterio González UANL</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario Dr. José Eleuterio González</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo León</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Lebovitz O, Barzilay E, Mazaki-Tovi S, Gat I, Achiron R, Gilboa Y. The clinical value of maternal and fetal Doppler parameters in low-risk postdates pregnancies - a prospective study. J Matern Fetal Neonatal Med. 2018 Nov;31(21):2893-2897. doi: 10.1080/14767058.2017.1359531. Epub 2017 Aug 9.</citation>
    <PMID>28738721</PMID>
  </reference>
  <reference>
    <citation>Lam H, Leung WC, Lee CP, Lao TT. The use of fetal Doppler cerebroplacental blood flow and amniotic fluid volume measurement in the surveillance of postdated pregnancies. Acta Obstet Gynecol Scand. 2005 Sep;84(9):844-8.</citation>
    <PMID>16097973</PMID>
  </reference>
  <reference>
    <citation>Arabin B, Becker R, Mohnhaupt A, Vollert W, Weitzel HK. Prediction of fetal distress and poor outcome in prolonged pregnancy using Doppler ultrasound and fetal heart rate monitoring combined with stress tests (II). Fetal Diagn Ther. 1994 Jan-Feb;9(1):1-6.</citation>
    <PMID>8142046</PMID>
  </reference>
  <reference>
    <citation>Tongsong T, Srisomboon J. Amniotic fluid volume as a predictor of fetal distress in postterm pregnancy. Int J Gynaecol Obstet. 1993 Mar;40(3):213-7.</citation>
    <PMID>8096472</PMID>
  </reference>
  <reference>
    <citation>Adiga P, Kantharaja I, Hebbar S, Rai L, Guruvare S, Mundkur A. Predictive value of middle cerebral artery to uterine artery pulsatility index ratio in hypertensive disorders of pregnancy. Int J Reprod Med. 2015;2015:614747. doi: 10.1155/2015/614747. Epub 2015 Feb 1.</citation>
    <PMID>25763408</PMID>
  </reference>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 9, 2018</study_first_submitted>
  <study_first_submitted_qc>October 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 11, 2018</study_first_posted>
  <last_update_submitted>October 27, 2019</last_update_submitted>
  <last_update_submitted_qc>October 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Universitario Dr. Jose E. Gonzalez</investigator_affiliation>
    <investigator_full_name>Flavio Hernández Castro</investigator_full_name>
    <investigator_title>Principal investigator Flavio Hernández Castro MD PhD</investigator_title>
  </responsible_party>
  <keyword>Late term pregnancy</keyword>
  <keyword>Doppler</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oligohydramnios</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

